Cytidine Deaminase Resolves Replicative Stress and Protects Pancreatic Cancer from DNA-Targeting Drugs.

Autor: Lumeau A; Centre de Recherches en Cancérologie de Toulouse, CRCT, Université de Toulouse, Inserm, CNRS, Toulouse, France., Bery N; Centre de Recherches en Cancérologie de Toulouse, CRCT, Université de Toulouse, Inserm, CNRS, Toulouse, France., Francès A; Centre de Recherches en Cancérologie de Toulouse, CRCT, Université de Toulouse, Inserm, CNRS, Toulouse, France., Gayral M; Centre de Recherches en Cancérologie de Toulouse, CRCT, Université de Toulouse, Inserm, CNRS, Toulouse, France., Labrousse G; Centre de Recherches en Cancérologie de Toulouse, CRCT, Université de Toulouse, Inserm, CNRS, Toulouse, France., Ribeyre C; Institut de Génétique Humaine, CNRS, Université de Montpellier, Montpellier, France., Lopez C; Centre de Recherches en Cancérologie de Toulouse, CRCT, Université de Toulouse, Inserm, CNRS, Toulouse, France., Nevot A; Centre de Recherches en Cancérologie de Toulouse, CRCT, Université de Toulouse, Inserm, CNRS, Toulouse, France., El Kaoutari A; Centre de Recherche en Cancérologie de Marseille, CRCM, Inserm, CNRS, Institut Paoli-Calmettes, Université Aix-Marseille, Marseille, France., Hanoun N; Centre de Recherches en Cancérologie de Toulouse, CRCT, Université de Toulouse, Inserm, CNRS, Toulouse, France., Sarot E; Centre de Recherches en Cancérologie de Toulouse, CRCT, Université de Toulouse, Inserm, CNRS, Toulouse, France., Perrier M; Centre de Recherches en Cancérologie de Toulouse, CRCT, Université de Toulouse, Inserm, CNRS, Toulouse, France., Pont F; Centre de Recherches en Cancérologie de Toulouse, CRCT, Université de Toulouse, Inserm, CNRS, Toulouse, France., Cerapio JP; Centre de Recherches en Cancérologie de Toulouse, CRCT, Université de Toulouse, Inserm, CNRS, Toulouse, France., Fournié JJ; Centre de Recherches en Cancérologie de Toulouse, CRCT, Université de Toulouse, Inserm, CNRS, Toulouse, France., Lopez F; Centre de Recherches en Cancérologie de Toulouse, CRCT, Université de Toulouse, Inserm, CNRS, Toulouse, France., Madrid-Mencia M; Centre de Recherches en Cancérologie de Toulouse, CRCT, Université de Toulouse, Inserm, CNRS, Toulouse, France., Pancaldi V; Centre de Recherches en Cancérologie de Toulouse, CRCT, Université de Toulouse, Inserm, CNRS, Toulouse, France.; Barcelona Supercomputing Center, Barcelona, Spain., Pillaire MJ; Institut de Pharmacologie et de Biologie Structurale, IPBS, Toulouse, France., Bergoglio V; Centre de Biologie Intégrée, CBI, Toulouse, France., Torrisani J; Centre de Recherches en Cancérologie de Toulouse, CRCT, Université de Toulouse, Inserm, CNRS, Toulouse, France., Dusetti N; Centre de Recherche en Cancérologie de Marseille, CRCM, Inserm, CNRS, Institut Paoli-Calmettes, Université Aix-Marseille, Marseille, France., Hoffmann JS; Laboratoire d'Excellence Toulouse Cancer (TOUCAN), Laboratoire de pathologie, Institut Universitaire du Cancer-Toulouse, Toulouse, France., Buscail L; Centre de Recherches en Cancérologie de Toulouse, CRCT, Université de Toulouse, Inserm, CNRS, Toulouse, France.; Service de gastroentérologie et d'hépatologie, CHU Rangueil, Université de Toulouse, Toulouse, France., Lutzmann M; Institut de Génétique Humaine, CNRS, Université de Montpellier, Montpellier, France., Cordelier P; Centre de Recherches en Cancérologie de Toulouse, CRCT, Université de Toulouse, Inserm, CNRS, Toulouse, France.

Publikováno v: Cancer research [Cancer Res] 2024 Apr 01; Vol. 84 (7), pp. 1013-1028.

Specific Disruption of Memory Reconsolidation of Conditioned Food Aversion in Snails by DNA Synthesis Inhibitors.

Autor: Solntseva SV; Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies, Moscow, Russia., Efimova OI; Vladimir Zelman Center for Neurobiology and Brain Rehabilitation, Skolkovo Institute of Science and Technology, Moscow, Russia., Nikitin VP; Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies, Moscow, Russia. nikitin_vp@academpharm.ru.

Publikováno v: Bulletin of experimental biology and medicine [Bull Exp Biol Med] 2024 Nov; Vol. 178 (1), pp. 11-16. Date of Electronic Publication: 2024 Nov 20.

Durvalumab with platinum-pemetrexed for unresectable pleural mesothelioma: survival, genomic and immunologic analyses from the phase 2 PrE0505 trial.

Autor: Forde PM; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA. pforde1@jhmi.edu.; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA. pforde1@jhmi.edu., Anagnostou V; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA. vanagno1@jhmi.edu.; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA. vanagno1@jhmi.edu., Sun Z; ECOG-ACRIN Biostatistics Center, Boston, MA, USA.; Frontier Science Foundation, Boston, MA, USA., Dahlberg SE; Boston Children's Hospital, Boston, MA, USA., Kindler HL; University of Chicago Medicine, Chicago, IL, USA., Niknafs N; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Purcell T; University of Washington School of Medicine & Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Santana-Davila R; University of Washington School of Medicine & Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Dudek AZ; Metro-Minnesota Community Oncology Research Consortium, St. Louis Park, MN, USA., Borghaei H; Fox Chase Cancer Center, Philadelphia, PA, USA., Lanis M; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Belcaid Z; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Smith KN; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Balan A; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., White JR; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Cherry C; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Ashok Sivakumar IK; Institute for Computational Medicine, Johns Hopkins University, Baltimore, MD, USA., Shao XM; Institute for Computational Medicine, Johns Hopkins University, Baltimore, MD, USA.; Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA., Chan HY; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Singh D; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Thapa S; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Illei PB; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Pardoll DM; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Karchin R; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Institute for Computational Medicine, Johns Hopkins University, Baltimore, MD, USA.; Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA., Velculescu VE; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA.; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Brahmer JR; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Ramalingam SS; Department of Hematology and Medical Oncology, Emory University School of Medicine, Winship Cancer Institute, Atlanta, GA, USA.

Publikováno v: Nature medicine [Nat Med] 2021 Nov; Vol. 27 (11), pp. 1910-1920. Date of Electronic Publication: 2021 Nov 08.

Influenza Therapeutics in Clinical Practice-Challenges and Recent Advances.

Autor: Beigel JH; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland 20892-9826, USA., Hayden FG; Division of Infectious Diseases and International Health, University of Virginia School of Medicine, Charlottesville, Virginia 22908, USA.

Publikováno v: Cold Spring Harbor perspectives in medicine [Cold Spring Harb Perspect Med] 2021 Apr 01; Vol. 11 (4). Date of Electronic Publication: 2021 Apr 01.

The Antitumor Effect of the DNA Polymerase Alpha Inhibitor ST1926 in Glioblastoma: A Proteomics Approach.

Autor: El-Baba C; Department of Biochemistry and Molecular Genetics, American University of Beirut, Beirut 1107 2020, Lebanon., Ayache Z; Department of Biochemistry and Molecular Genetics, American University of Beirut, Beirut 1107 2020, Lebanon., Goli M; Department of Chemistry and Biochemistry, Texas Tech University, Lubbock, TX 79409, USA., Hayar B; Department of Biochemistry and Molecular Genetics, American University of Beirut, Beirut 1107 2020, Lebanon., Kawtharani Z; Department of Biochemistry and Molecular Genetics, American University of Beirut, Beirut 1107 2020, Lebanon., Pisano C; Biogem, Institute of Molecular Biology and Genetics, 83031 Ariano Irpino, Italy., Kobeissy F; Department of Biochemistry and Molecular Genetics, American University of Beirut, Beirut 1107 2020, Lebanon.; Department of Neurobiology, Center for Neurotrauma, Multiomics and Biomarkers (CNMB), Morehouse School of Medicine, 720 Westview Dr. SW, Atlanta, GA 30310, USA., Mechref Y; Department of Chemistry and Biochemistry, Texas Tech University, Lubbock, TX 79409, USA., Darwiche N; Department of Biochemistry and Molecular Genetics, American University of Beirut, Beirut 1107 2020, Lebanon.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2023 Sep 14; Vol. 24 (18). Date of Electronic Publication: 2023 Sep 14.